iBio Ownership | Who Owns iBio?


OverviewForecastRevenueFinancialsChart

iBio Ownership Summary


iBio is owned by 34.00% institutional investors, 3.95% insiders, and 62.04% retail investors. Lynx1 capital management lp is the largest institutional shareholder, holding 10.06% of IBIO shares.

IBIO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockiBio34.00%3.95%62.04%
SectorHealthcare Stocks 42.64%10.86%46.50%
IndustryBiotech Stocks 45.45%10.77%43.78%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Lynx1 capital management lp1.06M10.06%$874.07K
Ikarian capital617.33K5.88%$511.02K
Ameriprise financial482.30K4.59%$399.25M
Opaleye management375.00K3.57%$310.43K
Boothbay fund management176.86K1.68%$146.41K
Vanguard group883.15K1.67%$1.70M
Geode capital management151.31K1.44%$125.25K
Two sigma securities45.08K0.43%$37.32K
Noesis capital mangement224.20K0.42%$432.71K
Blackrock funding, inc. /de42.73K0.41%$35.37K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Lynx1 capital management lp1.06M0.18%$874.07K
Noesis capital mangement224.20K0.06%$432.71K
Ikarian capital617.33K0.05%$511.02K
Opaleye management375.00K0.04%$310.43K
Mcia63.00K0.02%$141.75K
Two sigma securities45.08K0.01%$37.32K
Adar1 capital management27.00K0.00%$22.35K
Boothbay fund management176.86K0.00%$146.41K
Virtu financial41.90K0.00%$35.00K
Pfg investments21.50K0.00%$41.49K

Top Buyers

HolderShares% AssetsChange
Vanguard group883.15K-609.08K
Ameriprise financial482.30K0.00%482.30K
Noesis capital mangement224.20K0.06%224.20K
Ubs group126.56K-126.56K
Mcia63.00K0.02%63.00K

Top Sellers

HolderShares% AssetsChange
Lynx1 capital management lp1.06M0.18%-482.68K
Iridian asset management llc/ct---58.20K
Cubist systematic strategies---55.60K
Quadrature capital---28.85K
Adar1 capital management27.00K0.00%-27.82K

New Positions

HolderShares% AssetsChangeValue
Ameriprise financial482.30K0.00%482.30K$399.25M
Noesis capital mangement224.20K0.06%224.20K$432.71K
Mcia63.00K0.02%63.00K$141.75K
Hrt financial lp34.16K0.00%34.16K$28.00K
Pfg investments21.50K0.00%21.50K$41.49K

Sold Out

HolderChange
Fmr-1.00
City-4.00
Atlantic union bankshares-14.00
Harbour investments-40.00
Group one trading-156.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025326.67%3,569,98811.42%343.22%14-6200.00%
Jun 30, 202530-9.09%3,203,75823.84%324.72%13-23.53%2-
Mar 31, 20253313.79%2,587,118-0.97%263.21%17142.86%2-66.67%
Dec 31, 202429-6.45%2,612,4020.19%283.14%7-12.50%620.00%
Sep 30, 20243114.81%2,607,5126.38%303.74%8-5-44.44%

Recent Insider Transactions


DateNameRoleActivityValue
Jan 10, 2025Duran Felipe Chief Financial OfficerBuy$25.00K
Jan 10, 2025Brenner Martin See RemarksBuy$25.00K
Jan 10, 2025Banjak Marc Chief Legal OfficerBuy$25.00K
Jan 10, 2025Arkowitz David-Buy$50.00K
Jan 10, 2025Clark William D-Buy$5.00K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q4--
2025 Q17-
2024 Q4--
2024 Q3--

IBIO Ownership FAQ


Who Owns iBio?

iBio shareholders are primarily institutional investors at 34.00%, followed by 3.95% insiders and 62.05% retail investors. The average institutional ownership in iBio's industry, Biotech Stocks , is 45.45%, which iBio falls below.

Who owns the most shares of iBio?

iBio’s largest shareholders are Lynx1 capital management lp (1.06M shares, 10.06%), Ikarian capital (617.33K shares, 5.88%), and Ameriprise financial (482.3K shares, 4.59%). Together, they hold 20.53% of iBio’s total shares outstanding.

Does Blackrock own iBio?

BlackRock is not among the top 10 institutional shareholders of iBio.

Who is iBio’s biggest shareholder by percentage of total assets invested?

Lynx1 capital management lp is iBio’s biggest shareholder by percentage of total assets invested, with 0.18% of its assets in 1.06M iBio shares, valued at 874.07K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools